week 1 retatrutide Dosage & Titration: Complete Escalation Protocol (5-30 mg) Retatrutide Peptide Side Effects: My

GLP-1 receptor agonists have become a cornerstone of modern weight management, but they aren't prescribed to everyone

| 12 comments on LinkedIn

And eventually, it may be evidence payers, clinicians, employers, and patients all start asking for.

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies